Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
22.90
+0.16 (0.70%)
Apr 8, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Market Cap
Pelthos Therapeutics has a market cap or net worth of $76.84 million as of April 8, 2026. Its market cap has increased by 767.18% in one year.
Market Cap
76.84M
Enterprise Value
93.70M
1-Year Change
767.18%
Ranking
Category
Stock Price
$22.90
Market Cap Chart
Since February 16, 2024, Pelthos Therapeutics's market cap has increased from $27.68M to $76.84M, an increase of 177.57%. That is a compound annual growth rate of 61.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 76.84M | -19.69% |
| Dec 31, 2025 | 95.69M | 2,376.40% |
| Dec 31, 2024 | 3.86M | -86.04% |
| Feb 16, 2024 | 27.68M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 78.24M |
| Gain Therapeutics | 78.15M |
| aTyr Pharma | 77.96M |
| Gossamer Bio | 77.38M |
| Fortress Biotech | 75.68M |
| NRx Pharmaceuticals | 73.67M |
| Estrella Immunopharma | 73.38M |
| Cognition Therapeutics | 73.04M |